-
Novartis. Our research group at the Division of Physical Chemistry is part of this consortium, and the advertised position will allow a researcher to join this international effort. In this project we aim
-
-targeted radionuclide therapy. These drugs, such as Novartis’ recently approved Pluvicto for prostate cancer, may destroy the salivary glands because these tissues also express PSMA. This can cause severe
Searches related to physics
Enter an email to receive alerts for physics "Novartis" positions